| 000 | 01288 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250517133529.0 | ||
| 264 | 0 | _c20180316 | |
| 008 | 201803s 0 0 spa d | ||
| 022 | _a1578-1852 | ||
| 024 | 7 |
_a10.1016/S0213-005X(17)30002-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBlanco Arévalo, José Luis | |
| 245 | 0 | 0 |
_a[Darunavir as initial therapy for human immunodeficiency virus infection and as a strategy for switching regimen not motivated by virological failure]. _h[electronic resource] |
| 260 |
_bEnfermedades infecciosas y microbiologia clinica _cMay 2016 |
||
| 300 |
_a3-10 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAnti-HIV Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCobicistat _xtherapeutic use |
| 650 | 0 | 4 |
_aDarunavir _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 | _aDrug Resistance, Viral |
| 650 | 0 | 4 | _aDrug Substitution |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aRitonavir _xtherapeutic use |
| 650 | 0 | 4 | _aViral Load |
| 773 | 0 |
_tEnfermedades infecciosas y microbiologia clinica _gvol. 34 Suppl 1 _gp. 3-10 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0213-005X(17)30002-2 _zAvailable from publisher's website |
| 999 |
_c26778875 _d26778875 |
||